Hostname: page-component-7b7567c8c-2n9c9 Total loading time: 0 Render date: 2026-11-17T03:10:49.171Z Has data issue: false hasContentIssue false

The use of Short-Acting Relaxants in E.C.T.

Published online by Cambridge University Press:  08 February 2018

A. B. Monro
Affiliation:
Long Grove Hospital, Epsom
Anne K. Kirkland
Affiliation:
Long Grove Hospital, Epsom
A. Gillie
Affiliation:
Long Grove Hospital, Epsom
D. L. M. McNeill
Affiliation:
Long Grove Hospital, Epsom
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Since the introduction of curare to modify the contractions in E.C.T., the use of relaxants has become standard psychiatric practice. These substances reduce the risk of fractures and enable treatment to be given to patients who would otherwise be denied it owing to risks arising from concomitant physical disease. During recent years great efforts have been made to simplify the technique of muscle relaxation, in particular to evolve a method which is short in duration, free from undesirable side-effects and easy in use. In this short paper we give a description of our experience with three drugs recently introduced, namely, Suxamethonium Bromide or Brevidil “M” which we used in 111 treatments, Suxethonium Bromide or Brevidil “E” (70 treatments), and Suxamethonium Chloride or Scoline (653 treatments). These choline succinic ester derivatives have similar characteristics which can be considered together.

Information

Type
Part I.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1953 
Submit a response

eLetters

No eLetters have been published for this article.